Selinexor Enhances Natural Killer Cell Function Against Multiple Myeloma Cells

被引：0
|
作者：
Fisher, Jack G. [1 ]
Doyle, Amber D. P. [1 ]
Graham, Lara V. [1 ]
Forconi, Francesco [2 ]
Cragg, Mark S. [3 ,4 ]
Walker, Christopher J. [5 ]
Khakoo, Salim I. [1 ]
Blunt, Matthew D. [1 ]
机构：
[1] Univ Southampton, Sch Clin & Expt Sci, Fac Med, Southampton, Hants, England
[2] Univ Southampton, Sch Canc Sci, Fac Med, Southampton, Hants, England
[3] Univ Southampton, Antibody & Vaccine Grp, Ctr Canc Immunol, Southampton, Hants, England
[4] Univ Southampton, Antibody & Vaccine Grp, Ctr Canc Immunol, Fac Med, Southampton, Hants, England
[5] Karyopharm Therapeut, Newton, MA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179744
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The effect of elotuzumab on natural killer (NK) cell function against multiple myeloma (MM).
    Collins, S. M.
    Bakan, C. E.
    Alghothani, Y.
    Kwon, H.
    Balasa, B.
    Starling, G.
    Rice, A.
    Benson, D. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] The role of natural killer cells in immunity against multiple myeloma
    Godfrey, James
    Benson, Don M., Jr.
    LEUKEMIA & LYMPHOMA, 2012, 53 (09) : 1666 - 1676
  • [3] Natural killer cell immunotherapy against multiple myeloma: Progress and possibilities
    Liu, Pan
    Jin, Yanxia
    Sattar, Haseeb
    Liu, Hailing
    Xie, Weiling
    Zhou, Fuling
    JOURNAL OF LEUKOCYTE BIOLOGY, 2018, 103 (05) : 821 - 828
  • [4] Amelioration of natural killer cell function driven by invariant natural killer T cell activation in multiple myeloma
    Yamasaki, Satoru
    Iyoda, Tomonori
    Hidaka, Michihiro
    Kawano, Fumio
    Abe, Yu
    Suzuki, Kenshi
    Kadowaki, Norimitsu
    Shimizu, Kanako
    Fujii, Shin-ichiro
    CANCER SCIENCE, 2018, 109 : 109 - 109
  • [5] Restoration of NK cell function against multiple myeloma cells by an adjunctive effect of activated invariant natural killer T (NKT) cells
    Iyoda, Tomonori
    Yamasaki, Satoru
    Hidaka, Michihiro
    Kawano, Fumio
    Abe, Yu
    Suzuki, Kenshi
    Kadowaki, Norimitsu
    Shimizu, Kanako
    Fujii, Shin-ichiro
    CYTOKINE, 2017, 100 : 128 - 129
  • [6] SILENCING THE INHIBITORY CHECKPOINT CD96 ENHANCES THE CYTOTOXIC POTENTIAL OF NATURAL KILLER CELLS AGAINST MULTIPLE MYELOMA
    Duggan, T.
    Chauhan, S.
    Daly, J.
    Sarkar, S.
    O'Dwyer, M.
    HAEMATOLOGICA, 2018, 103 : 16 - 16
  • [7] DEVELOPING AND IMPROVING A NATURAL KILLER CELL BASED MODEL AGAINST MULTIPLE MYELOMA
    Giraldos, D.
    Reina-Ortiz, C.
    Sancho-Camon, N.
    Naval, J.
    Anel, A.
    HUMAN GENE THERAPY, 2022, 33 (7-8) : A39 - A39
  • [8] Targeting Caveolin-1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell-Mediated Immunotherapy
    Zhan, Dewen
    Du, Zhimin
    Zhang, Shang
    Huang, Juanru
    Zhang, Jian
    Zhang, Hui
    Liu, Zhongrui
    Menu, Eline
    Wang, Jinheng
    ADVANCED SCIENCE, 2025, 12 (04)
  • [9] Restoring Natural Killer Cell immunity against Multiple Myeloma in the era of New Drugs
    Pittari, Gianfranco
    Vago, Luca
    Festuccia, Moreno
    Bonini, Chiara
    Mudawi, Deena
    Giaccone, Luisa
    Bruno, Benedetto
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [10] Natural Killer Cells in the Malignant Niche of Multiple Myeloma
    Venglar, Ondrej
    Bago, Julio Rodriguez
    Motais, Benjamin
    Hajek, Roman
    Jelinek, Tomas
    FRONTIERS IN IMMUNOLOGY, 2022, 12
12345